SPECTRUM PHARMACEUTICALS, INC.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 1987-01-01
- Employees
- 101
- Market Cap
- -
- Website
- http://www.sppirx.com
FDA Rejects Poziotinib for HER2-Mutated NSCLC Following Advisory Committee's Negative Vote
The FDA has issued a complete response letter for poziotinib, Spectrum Pharmaceuticals' pan-HER2 inhibitor, rejecting its application for HER2 exon 20 insertion-mutated non-small cell lung cancer treatment.
© Copyright 2025. All Rights Reserved by MedPath